160 related articles for article (PubMed ID: 22933339)
1. A sequential testing approach to detecting multiple change points in the proportional hazards model.
He P; Fang L; Su Z
Stat Med; 2013 Mar; 32(7):1239-45. PubMed ID: 22933339
[TBL] [Abstract][Full Text] [Related]
2. A Monte Carlo approach for change-point detection in the Cox proportional hazards model.
Liu M; Lu W; Shao Y
Stat Med; 2008 Aug; 27(19):3894-909. PubMed ID: 18254131
[TBL] [Abstract][Full Text] [Related]
3. Estimating the survival functions for right-censored and interval-censored data with piecewise constant hazard functions.
He P; Kong G; Su Z
Contemp Clin Trials; 2013 Jul; 35(2):122-7. PubMed ID: 23664967
[TBL] [Abstract][Full Text] [Related]
4. Estimation of a decreasing hazard of patients with acute coronary syndrome.
van Geloven N; Martin I; Damman P; de Winter RJ; Tijssen JG; Lopuhaä HP
Stat Med; 2013 Mar; 32(7):1223-38. PubMed ID: 22829475
[TBL] [Abstract][Full Text] [Related]
5. A hybrid approach to predicting events in clinical trials with time-to-event outcomes.
Fang L; Su Z
Contemp Clin Trials; 2011 Sep; 32(5):755-9. PubMed ID: 21645644
[TBL] [Abstract][Full Text] [Related]
6. Estimating a treatment effect with the accelerated hazards models.
Chen YQ; Wang M
Control Clin Trials; 2000 Aug; 21(4):369-80. PubMed ID: 10913811
[TBL] [Abstract][Full Text] [Related]
7. A proportional hazards model taking account of long-term survivors.
Tsodikov A
Biometrics; 1998 Dec; 54(4):1508-16. PubMed ID: 9883549
[TBL] [Abstract][Full Text] [Related]
8. The consequences of proportional hazards based model selection.
Campbell H; Dean CB
Stat Med; 2014 Mar; 33(6):1042-56. PubMed ID: 24136328
[TBL] [Abstract][Full Text] [Related]
9. Polynomial spline estimation and inference of proportional hazards regression models with flexible relative risk form.
Huang JZ; Liu L
Biometrics; 2006 Sep; 62(3):793-802. PubMed ID: 16984322
[TBL] [Abstract][Full Text] [Related]
10. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
Westphal M; Ram Z; Riddle V; Hilt D; Bortey E;
Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400
[TBL] [Abstract][Full Text] [Related]
11. Testing for crossover of two hazard functions using Gail and Simon's method.
Chen YH; Liu GH
J Biopharm Stat; 2006 May; 16(3):313-26. PubMed ID: 16724487
[TBL] [Abstract][Full Text] [Related]
12. Accelerated hazards regression model and its adequacy for censored survival data.
Chen YQ
Biometrics; 2001 Sep; 57(3):853-60. PubMed ID: 11550937
[TBL] [Abstract][Full Text] [Related]
13. A semiparametric marginal mixture cure model for clustered survival data.
Niu Y; Peng Y
Stat Med; 2013 Jun; 32(14):2364-73. PubMed ID: 23203908
[TBL] [Abstract][Full Text] [Related]
14. Bayesian inference in a piecewise Weibull proportional hazards model with unknown change points.
Casellas J
J Anim Breed Genet; 2007 Aug; 124(4):176-84. PubMed ID: 17651319
[TBL] [Abstract][Full Text] [Related]
15. The Average Hazard Ratio - A Good Effect Measure for Time-to-event Endpoints when the Proportional Hazard Assumption is Violated?
Rauch G; Brannath W; Brückner M; Kieser M
Methods Inf Med; 2018 May; 57(3):89-100. PubMed ID: 29719915
[TBL] [Abstract][Full Text] [Related]
16. An EM-based semi-parametric mixture model approach to the regression analysis of competing-risks data.
Ng SK; McLachlan GJ
Stat Med; 2003 Apr; 22(7):1097-111. PubMed ID: 12652556
[TBL] [Abstract][Full Text] [Related]
17. Under-smoothed kernel confidence intervals for the hazard ratio based on censored data.
Tu D
Biom J; 2007 Jun; 49(3):474-83. PubMed ID: 17623350
[TBL] [Abstract][Full Text] [Related]
18. Dealing with competing risks: testing covariates and calculating sample size.
Pintilie M
Stat Med; 2002 Nov; 21(22):3317-24. PubMed ID: 12407674
[TBL] [Abstract][Full Text] [Related]
19. Tests for treatment group differences in the hazards for survival, before and after the occurrence of an intermediate event.
Bebchuk JD; Betensky RA
Stat Med; 2005 Feb; 24(3):359-78. PubMed ID: 15568187
[TBL] [Abstract][Full Text] [Related]
20. The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials.
Péron J; Roy P; Ozenne B; Roche L; Buyse M
JAMA Oncol; 2016 Jul; 2(7):901-5. PubMed ID: 27124210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
